USPH Stock Analysis: Buy, Sell, or Hold?
USPH - US Physical Therapy Inc
$79.06
-1.07 (-1.34%)
▼
5d:
+6.01%
30d:
+10.87%
90d:
+11.01%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 05, 2026
2d
Get Alerted When USPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: USPH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: USPH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$129.59
Based on 10.4% avg growth
INTRINSIC VALUE TODAY
$80.46
1.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: USPH is currently trading at $79.06, which is considered extended relative to its 30-day fair value range of $69.30 to $76.66. The stock's valuation (Forward PE: 23.2) is in line with its historical norms (23.3). Remarkably, the market is currently pricing in an annual earnings decline of 0.2% over the next few years. This pessimistic expectation contrasts with the company's recent 23.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, USPH is in a downtrend. The price is approaching resistance at $80.75. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: USPH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $93.67 (+18.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, USPH is in a downtrend. The price is approaching resistance at $80.75. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: USPH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $93.67 (+18.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$69.30 -
$76.66
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
59.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($93.67)
Trading Range Analysis
30-Day Trading Range
$69.30 -
$76.66
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$71.23
Resistance Level
$80.75
Current Trend
Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.16
Wall Street Target
$93.67
(+18.5%)
Revenue Growth (YoY)
7.9%
Earnings Growth (YoY)
23.6%
Profit Margin
4.4%
Valuation Discount vs History
-0.2% cheaper
PE vs Historical
23.2 vs 23.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.2%
(market-implied from PE analysis)
1-Year Target
$78.90
(0%)
2-Year Target
$78.74
(0%)
3-Year Target
$78.59
(-1%)
3-Yr Target (if PE normalizes)
(PE: 23→23)
$79.05
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.2, Growth: 16.7%)
$125.57
(+59%)
Base:
(SPY PE: 20.7, Growth: 16.7%)
$112.38
(+42%)
Bear:
(PE: 17.6, Growth: 16.7%)
$95.52
(+21%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (29x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Forward PE: 29.07 | Forward EPS (Implied): $2.72
Bull Case
$95.46
(+21%)
Analyst growth 15.0%, PE expands to 30.5
Base Case
$79.06
(0%)
Market implied 0.0%, PE stable at 29.1
Bear Case
$60.48
(-24%)
Severe decline -15.0%, PE contracts to 26.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 23.2 to 23.3
Stabilization Target:
$79.53
(+0.6%)
PE Expansion Potential:
+0.6%
Share & Embed Analysis
Last updated: August 02, 2026 3:06 PM ET
Data refreshes hourly during market hours. Next update: 4:06 PM
Data refreshes hourly during market hours. Next update: 4:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is USPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Graham D Reeve
SELL
662 shares
2026-03-11
Richard Binstein
SELL
3000 shares
2026-03-06
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$277 | 52 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$453 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 46 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$33 | 61 BUY |
